Dr. Suzan Obagi Named Obagi Cosmeceuticals’ First Chief Medical Director

Obagi Cosmeceuticals LLC, a leader in skincare innovation, has appointed Dr. Suzan Obagi the company’s first chief medical director (CMD). 

 

Obagi is a subsidiary of Waldencast plc, a global multi-brand beauty and wellness platform and publicly listed company. 

 

“I am thrilled to be taking on a more formal role at Obagi as the company’s first-ever chief medical director,” said Dr. Obagi. “Obagi has an incredible reputation for delivering high-quality, medical-grade skincare solutions. In this new position, I am looking forward to impacting upstream product development to deliver new innovations that solve more skin concerns for more patients and consumers, as well as educating the professional community on Obagi’s transformational, science-backed skincare solutions.”

 

A leading board-certified dermatologist and cosmetic surgeon, Obagi is recognized for her contributions to the fields of dermatology, cosmetic surgery and skincare. Throughout her career, she has become an authority in aesthetic dermatology, medical-grade skincare, anti-aging treatments and skin health, focusing her practice across a range of skin types, including darker skin. 

 

As CMD, Obagi will play a pivotal role in shaping Obagi's product development, portfolio refinement, research initiatives and educational programs to ensure Obagi continues to provide the “gold standard” for skincare to the physician-dispensed market, the company said. 

 

Obagi is known for its targeted medical-grade solutions that provide transformative results. Its Obagi Nu-Derm System, Professional-C, ELASTIderm and Obagi Nu-Cil product portfolios treat common skin concerns, including hyperpigmentation, fine lines and wrinkles, hydration, brightening skin and acne.

Obagi Medical Skincare @ 35

Waldencast Goes Public on Nasdaq Featuring Obagi Skincare, Milk Makeup in Business Combination

Waldencast To Acquire Obagi and Milk Makeup in Three-Way $1.2 Billion Transaction